Who is sponsoring NCT04496440?

NCT04496440 is sponsored by DR R C Agrawal.

What drugs are being tested in NCT04496440?

Interventions in NCT04496440: Contracture Correction Therapy.

What condition does NCT04496440 study?

NCT04496440 studies Knee Osteoarthritis, Arthroplasty, Knee.

Is NCT04496440 still recruiting?

NCT04496440 is currently completed. Last updated 25 July 2023.

Last reviewed 2023-07-25 · How we verify

NCT04496440

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Attempt to Find Out Root Cause of a Pain Producing Knee Disease

Completed Last updated 25 July 2023

What this trial tests

trial testing Contracture Correction Therapy in Knee Osteoarthritis in 138 participants. Completed in 30 March 2018.

Timeline

23 March 2017

Primary endpoint
30 December 2017

30 March 2018

Quick facts

Lead sponsor	DR R C Agrawal
Status	Completed
Study type	OBSERVATIONAL
Enrollment	138
Start date	23 March 2017
Primary completion	30 December 2017
Estimated completion	30 March 2018
Sites	6 locations across India

Drugs / interventions tested

Contracture Correction Therapy

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Arthroplasty — all drugs for Arthroplasty →
Knee — all drugs for Knee →

Sponsor

DR R C Agrawal

Who can join

Adults 30 to 80, any sex, with Knee Osteoarthritis or Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was focused on a type of arthritis (knee) in which patients develop pain with disabilities in sitting and walking etc. In advance stage the person is bereft of his/her personal physical activities. The prevalent treatment is temporary and dis-satisfactory. A new treatment was designed and a trial was conducted on 125 patients (100 in the trial group, 25 in the control group) for a duration of six months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04496440 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by DR R C Agrawal
Last refreshed: 25 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04496440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing